Clinical trial
The Association Between Blood Routine Parameters Combined With Clinicopathological Characteristics and Breast Cancer Prognosis: a Real-world Study
NCT07584213 is registered in ClinicalTrials.gov with Wenjin Yin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Association Between Blood Routine Parameters Combined With Clinicopathological Characteristics and Breast Cancer Prognosis: a Real-world Study
- Lead sponsor
- Wenjin Yin
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 1, 2026
- Completion date
- May 1, 2027
- Enrollment
- 2,946 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer invasive